Skip to main navigation Skip to search Skip to main content

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.

  • Jürgen Prattes (First author)
  • , J Wauters
  • , DR Giacobbe
  • , J Salmanton-García
  • , J Maertens
  • , M Bourgeois
  • , M Reynders
  • , L Rutsaert
  • , N van Regenmortel
  • , P Lormans
  • , S Feys
  • , Alexander Christian Reisinger
  • , OA Cornely
  • , T Lahmer
  • , M Valerio
  • , L Delhaes
  • , K Jabeen
  • , J Steinmann
  • , M Chamula
  • , M Bassetti
  • Stefan Hatzl, R Rautemaa-Richardson, P Koehler, K Lagrou, Martin Hönigl*, ECMM-CAPA Study Group, Marina Linhofer (Collaborator), Jonas Gregor Frost (Collaborator), Philipp Eller (Collaborator), Peter Zechner (Collaborator), Robert Krause (Collaborator)
*Corresponding author for this work

Research output: Contribution to journalResearch article

191 Citations (Web of Science)
Original languageEnglish
JournalClinical Microbiology and Infection
DOIs
Publication statusPublished - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Branches of science

  • 301 Medical-Theoretical Sciences, Pharmacy
  • 302 Clinical Medicine
  • 305 Other Human Medicine, Health Sciences

Research Fields

  • Microbiome and Infection
  • Sustainable Health Research

Cite this